BofA Securities raised the price target for the Paychex Inc. (NASDAQ:PAYX) stock from ‘an Underperform’ to ‘a Neutral’. The rating was released on March 09, 2023, according to finviz. We previously noted in another research note published on January 11, 2023 by Cowen that upgraded the stock from a Market perform to an Outperform with a price target of $145 for PAYX stock. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $125. The stock was downgraded by Citigroup, who disclosed in a research note on October 05, 2021, from Buy to Neutral and set the price objective to $125.
More Stories
NeoGenomics Inc. (NEO) Stock Experiences Incredible Growth
Piper Sandler raised the price target for the NeoGenomics Inc. (NASDAQ:NEO) stock to ‘an Overweight’. The rating was released on June 03,
Head to Head Analysis: Apollo Investment (NASDAQ:AINV) and Tri-Continental (NYSE:TY)
Tri-Continental (NYSE:TY – Get Rating) and Apollo Investment (NASDAQ:AINV – Get Rating) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses…
Veru Inc. (NASDAQ:VERU) stock Posted Gross Margin of 81.40 percent in Last Year: Is Justifiable?
Jefferies raised the price target for the Veru Inc. (NASDAQ:VERU) stock to ‘a Buy’. The rating was released on April 13, 2021, according t
The Technical Story of Rigel Pharmaceuticals Inc. (RIGL) Stock
Citigroup raised the price target for the Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) stock from ‘a Buy’ to ‘a Neutral’. The ra
Nasdaq Plummets To Lowest Level In Over A Year In Sell-Off On Wall Street
(RTTNews) – After recovering from an early sell-off in the previous session, stocks showed a substantial move back to the downside during trading …
Swissquote : First half of 2023 Report
Ad hoc announcement pursuant to Art. 53 LR Media information … | June 10, 2023